Yan, Connie H.
Coleman, Chandler
Nabulsi, Nadia A.
Chiu, Brian C.-H.
Ko, Naomi Y.
Hoskins, Kent
Calip, Gregory S. http://orcid.org/0000-0002-7744-3518
Funding for this research was provided by:
National Cancer Institute (U54CA202995, U54CA202997, U54CA203000)
Article History
Received: 7 April 2021
Accepted: 2 July 2021
First Online: 9 July 2021
Declarations
:
: At the time of submission, Gregory S. Calip reports employment with Flatiron Health, Inc, which is an independent subsidiary of the Roche Group and has received research funding from Pfizer, Inc. awarded to the University of Illinois at Chicago for work unrelated to this study. Chandler Coleman reports current employment with AbbVie, Inc. at the time of submission. All other authors have no conflict of interest to declare.
: The data used in the study were de-identified and compliant with the Health Insurance Portability and Accountability Act (HIPAA). This study was determined to be exempt by the Institutional Review Board of the University of Illinois at Chicago.
: The Institutional Review Board of the University of Illinois at Chicago determined this study to be exempt from obtaining informed consent from individual participants.